Skip to content
Governance Register

← US public companies

Mehra Anand

SEC-identified person · CIK 1590102 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Aclaris Therapeutics, Inc. ACRS Director filed 2015–2026
Merus N.V. MRUS Director filed 2020–2025
Spark Therapeutics, Inc. ONCE Director filed 2015–2019
Nextcure, Inc. NXTC Officer filed 2019–2019
Galera Therapeutics, Inc. GRTX Officer filed 2019–2019
Entasis Therapeutics Holdings Inc. [ETTX] Officer filed 2018–2018
Principia Biopharma Inc. PRNB Officer filed 2018–2018
Iterum Therapeutics plc ITRM Officer filed 2018–2018
Marinus Pharmaceuticals, INC. NASDAQMRNS Director filed 2014–2016
Synlogic, INC. SYBX Officer filed 2015–2015
Atyr Pharma INC LIFE Officer filed 2015–2015
Aerie Pharmaceuticals INC AERI Director filed 2013–2015
Ocugen, Inc. OCGN Officer filed 2014–2014
Alimera Sciences INC ALM Officer filed 2014–2014
Versartis, Inc. VSAR Officer filed 2014–2014

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.